A new breast cancer drug has been unveiled to help women in the late stages of the disease. Known as T-DM1-, it combines the antibody Herceptin with a chemotherapy agent to seek out cancerous cells.

Please wait while this video loads. If it doesn't load after a few seconds you may need to have Adobe Flash installed.

Article Tags